Sunmax Biotechnology
4728.TWO
12.76 USD
0.47
+3.82%
s
Overview
Last close
12.76 usd
Market cap
695.13M usd
52 week high
16.58 usd
52 week low
10.34 usd
Target price
N/A usd
Valuation
P/E
26.2081
Forward P/E
30.7692
Price/Sales
9.6894
Price/Book Value
14.92
Enterprise Value
649.63M usd
EV/Revenue
9.4146
EV/EBITDA
16.703
Key financials
Revenue TTM
69.00M usd
Gross Profit TTM
54.56M usd
EBITDA TTM
36.93M usd
Earnings per Share
0.47 usd
Dividend
0.38 usd
Total assets
62.95M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.
- Symbol4728.TWO
- ExchangeTWO
- IsinTW0004728001
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterTainan City
- Web sitehttps://www.sunmaxbiotech.com
